BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
9.36
-0.30 (-3.11%)
At close: Jun 27, 2025, 4:00 PM
9.54
+0.18 (1.92%)
After-hours: Jun 27, 2025, 7:51 PM EDT
BioCryst Pharmaceuticals Analyst Ratings
Total Analysts
8
Consensus Rating
Buy
Price Target
$16.75
Upside
+78.95%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Needham | Needham | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +81.62% | Jun 27, 2025 |
Needham | Needham | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +81.62% | Jun 25, 2025 |
Barclays | Barclays | Hold Maintains $8 → $11 | Hold | Maintains | $8 → $11 | +17.52% | May 7, 2025 |
RBC Capital | RBC Capital | Buy Reiterates $11 → $13 | Buy | Reiterates | $11 → $13 | +38.89% | May 6, 2025 |
JP Morgan | JP Morgan | Buy Maintains $10 → $13 | Buy | Maintains | $10 → $13 | +38.89% | May 6, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +220.51% | May 6, 2025 |
Needham | Needham | Strong Buy Maintains $15 → $17 | Strong Buy | Maintains | $15 → $17 | +81.62% | May 6, 2025 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $20 | Buy | Initiates | $20 | +113.68% | Apr 29, 2025 |
RBC Capital | RBC Capital | Buy Reiterates $11 | Buy | Reiterates | $11 | +17.52% | Apr 11, 2025 |
Needham | Needham | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +60.26% | Apr 10, 2025 |
Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $18 | Buy | Reiterates | $18 | +92.31% | Mar 3, 2025 |
RBC Capital | RBC Capital | Buy Reiterates $10 → $11 | Buy | Reiterates | $10 → $11 | +17.52% | Feb 25, 2025 |
Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $18 | Buy | Reiterates | $18 | +92.31% | Feb 25, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +220.51% | Feb 25, 2025 |
JMP Securities | JMP Securities | Buy Reiterates $18 | Buy | Reiterates | $18 | +92.31% | Jan 31, 2025 |
Evercore ISI Group | Evercore ISI Group | Buy Maintains $10 → $12 | Buy | Maintains | $10 → $12 | +28.21% | Jan 13, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.